KURA | Kura OncologyNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$9.88
+$0.09 (+0.92%)

Kura Oncology (KURA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Jun 2026, and a death cross is projected within 30 bars. On both the daily and the weekly, price sits between the 50 and the 200; on the 4-hour it is below both.

Timeframe summary

Weekly as of 30 Oct 16:00 ET

Price
between the two $10.26 vs 50 $9.93 / 200 $11.94
Projection
No cross projected
Test
No active test
Last cross
Death cross week of 21 Apr 2025 ยท projected 26 bars out

4-hour as of 3 Nov 16:00 ET

Price
below both $9.88 vs 50 $10.12 / 200 $10.80
Projection
No cross projected
Test
No active test
Last cross
Death cross 19 Oct 2026 ยท projected 20 bars out

Cross history

27
crosses on record since 2018
13 golden14 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
19 Oct 2026Death4-hour20 bars outNot tested
22 Jun 2026Golden flatdaily5 bars outNot tested
5 May 2026Golden4-hour26 bars out1 bar cross test
23 Mar 2026Death moderatedaily13 bars out4 bar cross test
22 Jan 2026Death4-hour27 bars outNot tested

About KURA

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$20.1M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.